Approval · Notice of Compliance 20433 · 2018
APRALAN: Notice of Compliance 20433
Issued February 2, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20433
- Date
- February 2, 2018
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APRALAN | 00818542 | Cancelled Post Market |
Medicinal ingredients
- APRAMYCIN SULFATE 50 MG per JAR